If you take another look at the November strategy update you will see RAC is positioning to achieve accelerated approval (i.e. approval from Phase 2). I can’t emphasise enough for everyone to study G1 therapeutics and their path to market.
I do agree that RAC has faced some macro headwinds just like the entire sector, but until Feb 2023 we were going pretty well with a SP above $2.25. The collapse of the SP to 74c in August 2023 was entirely self inflicted. The recent SP weakness is driven by a combination of a slow news period as we transition from RC110 to RC220 combined with some less than helpful selling from a single individual.
The good news is none of this will have any impact on the company by the end of the year. What will matter is accomplishing what we have promised.
- Forums
- ASX - By Stock
- RAC
- RAC - Charts & Price Action
RAC - Charts & Price Action, page-19335
-
- There are more pages in this discussion • 3,399 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.55 |
Change
0.020(1.31%) |
Mkt cap ! $260.7M |
Open | High | Low | Value | Volume |
$1.56 | $1.60 | $1.53 | $78.30K | 50.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 493 | $1.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 2773 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 493 | 1.545 |
4 | 8409 | 1.515 |
2 | 3250 | 1.510 |
5 | 20647 | 1.505 |
8 | 70897 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.565 | 2773 | 1 |
1.570 | 700 | 1 |
1.575 | 534 | 1 |
1.600 | 23239 | 1 |
1.650 | 17029 | 2 |
Last trade - 14.41pm 17/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online